Thoracic Oncology
Clinical research in locally advanced and metastatic non-small cell lung cancer with interest in combining immunotherapy and carbon ion radiotherapy in advanced disease settings.
- Non-small cell lung cancer
- Metastatic disease
- Immune checkpoint inhibitors
Focus on treatment strategies for patients with limited local control options and persistent systemic disease burden.
Genitourinary Oncology
Research activity in locally advanced and metastatic urothelial carcinoma, with attention to advanced malignancies where radiotherapy and immune-based treatment are relevant therapeutic domains.
- Urothelial carcinoma
- Metastatic cancer
- Oncologic immunotherapy
Interest in palliative treatment approaches for disease control in disseminated urinary tract cancer.
Melanoma and Cutaneous Oncology
Clinical interest in unresectable and metastatic melanoma, particularly in settings where checkpoint blockade is integrated with particle-based radiation for advanced solid tumours.
- Melanoma
- Unresectable disease
- Radiation-immunotherapy combinations
Relevant to patients with advanced skin cancer requiring non-surgical disease management.
Head and Neck Cancer
Research involvement in recurrent and metastatic head & neck squamous cell carcinoma, addressing a high-need area in advanced solid tumour care.
- Head & neck squamous cell carcinoma
- Recurrent and metastatic cancer
- Palliative oncology
Therapeutic interest extends to patients with limited curative options and substantial symptom burden.
Particle Therapy and Immuno-Oncology
Work centered on carbon ion radiotherapy combined with immune checkpoint inhibitors across advanced malignancies, reflecting a focus on innovative local and systemic cancer treatment domains.
- Carbon ion radiotherapy
- Immune checkpoint inhibition
- Advanced solid cancers
Clinical interest spans tumour types in which integrating radiation and immunotherapy may support disease control in the palliative setting.
